| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/14/2008 | CN101176757A Pomegranate leaf extract preparations |
| 05/14/2008 | CN101176756A Mulberry schizandrae honey oral liquid and technique of preparing the same |
| 05/14/2008 | CN101176745A Method for making chinese medicine radix astragali |
| 05/14/2008 | CN101176738A Deer tire puffing particle |
| 05/14/2008 | CN101176737A Pharmaceutical composition of chicken bile and preparation thereof |
| 05/14/2008 | CN101176728A Capsule for preventing and treating fatty liver and preparation method thereof |
| 05/14/2008 | CN101176698A Product and method for eliminating oral cavity bitter |
| 05/14/2008 | CN101176552A Abdomen-setting antidiarrheal stomachic medicinal tea gruel cake |
| 05/14/2008 | CN101176551A Health food for curing chronic diarrhea and its manufacturing method |
| 05/14/2008 | CN100387602C Chelerythrine compound and its preparing method |
| 05/14/2008 | CN100387597C Amide substituted imidazopyridines |
| 05/14/2008 | CN100387287C Chinese medicinal preparation for treating diziness and preparation process thereof |
| 05/14/2008 | CN100387271C Medicine for treating hepatitis B |
| 05/14/2008 | CN100387269C Schisandra chinensis soft capsule |
| 05/14/2008 | CN100387268C Use of composition in preparing medicine for preventing and treating aphtha |
| 05/14/2008 | CN100387267C Medicine and food dual purpose Chinese medicinal product for preventing and treating aphtha and toothache and its manufacturing method |
| 05/14/2008 | CN100387264C Suppository of Chinese traditional medicine for improving intestine motivity and its preparation method |
| 05/14/2008 | CN100387263C Medicinal composition for treating hepatopathy, and its preparing mehtod and use |
| 05/14/2008 | CN100387262C Hedyotis herba powder injection |
| 05/14/2008 | CN100387258C Liver-nourishing kidney protecting fat lowering tea |
| 05/14/2008 | CN100387256C Medicine for treating gastric, anal and intestinal diseases |
| 05/14/2008 | CN100387252C Soft capsule with peppermint oil as raw material medicine for treating gallbladder disease |
| 05/14/2008 | CN100387249C Traditional Chinese medicine formulation for treating ulcer |
| 05/14/2008 | CN100387246C Pharmaceutical composition for treating liver disease and its preparation and application |
| 05/14/2008 | CN100387242C American ginseng and royal jelly soft capsule |
| 05/14/2008 | CN100387237C Beta-L-2'deoxy-nucleosides for the treatment of hepatitis B |
| 05/14/2008 | CN100387230C Pharmaceutical combination prepared by cannabis extract |
| 05/14/2008 | CN100387218C Immune globulin G biological factor oral detergent |
| 05/14/2008 | CN100387144C Method for preparing digestion-promoting spleen-invigorating soybean milk powder with micron chickens gizzard-membrane powder, coix seed powder, white hyacinth bean powder, yam powder and pine pollen |
| 05/14/2008 | CN100387143C Method for preparing yang-invigorating, fatigue-alleviating soybean milk powder with micron pine pollen, antler powder, deer bone powder, deer sinew powder, bull penis powder and donkey penis powder |
| 05/13/2008 | US7371819 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction |
| 05/13/2008 | US7371810 Tachykinin peptides, precursor peptides thereof and genes encoding the same |
| 05/13/2008 | US7371777 Such as 2-(3-{[(4-ethoxybenzoyl)amino]methyl}-4-ethoxybenzyl)-tetrahydro-2-furancarboxylic acid; antihyperglycemia and antihyperlipemia action |
| 05/13/2008 | US7371775 nonhydroscopic, suitable for preparation of metered dose of 7-carboxymethyloxy-3',4',5-trimethoxy flavone (mucus protecting activity for gastrointestinal tract); storage stability; methylation of 3',5,7-trihydroxy-4'-methoxy flavone-7-rutinoside, followed by acetylation and deprotection |
| 05/13/2008 | US7371767 Heteroaryl substituted pyrrole modulators of metabotropic glutamate receptor-5 |
| 05/13/2008 | US7371756 Use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts |
| 05/13/2008 | US7371747 Cyanoalkylamino derivatives as protease inhibitors |
| 05/13/2008 | US7371723 Therapeutic agents comprising pro-apoptotic proteins |
| 05/13/2008 | US7371535 Detect binding with cells transfected with DNA |
| 05/13/2008 | US7371386 Conserved motif of hepatitis C virus E2/NS1 region |
| 05/13/2008 | US7371383 Genetic enginieered mixtures of complementary determining regions(CDR) antigens used for analyzing neutralizing epitopes and for prophylaxis of allergies and respiratory system disorders |
| 05/13/2008 | US7371375 Protein |
| 05/13/2008 | US7371373 For diagnosis, prevention, or treatment of diseases responsive to therapy with interferon- beta; free of human serum albumin; stability |
| 05/13/2008 | US7371069 Manikin and eye device apparatus, methods and articles of manufacture |
| 05/13/2008 | CA2437814C Human monoclonal antibodies to fc alpha receptor (cd89) |
| 05/13/2008 | CA2410234C 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinyl in pure crystalline form and process for synthesis |
| 05/13/2008 | CA2259012C S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders |
| 05/13/2008 | CA2184916C Use of fibroblast growth factors to stimulate bone growth |
| 05/08/2008 | WO2008053913A1 Sulfonylurea derivative capable of selectively inhibiting mmp-13 |
| 05/08/2008 | WO2008053892A1 Pharmaceutical for promoting functional regeneration of damaged tissue |
| 05/08/2008 | WO2008053331A1 Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (ppar). |
| 05/08/2008 | WO2008053224A1 Treatment of gastrointestinal diseases |
| 05/08/2008 | WO2008053219A2 Composition for the treatment of gastrointestinal diseases |
| 05/08/2008 | WO2008052995A1 Peptides containing tryptophan |
| 05/08/2008 | WO2008052468A1 New lactobacillus rhamnosus strain, its pharmaceutical composition and the uses thereof, and the method for preparation |
| 05/08/2008 | WO2008052410A1 A supermolecule composition of water-soluble coenzyme q10 and preparation method thereof |
| 05/08/2008 | WO2007149797A3 Use of organic compounds |
| 05/08/2008 | WO2007044062A8 Bile preparations for gastrointestinal disorders |
| 05/08/2008 | US20080108660 such as 4-{[4-({[(3-isopropyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}tetrahydro-2H-pyran-4-carboxylic acid; serotonin receptor agonist; antidepressant, anxiolytic agent, analgesic, cognition activator; less toxicity, good absorption, and metabolic stability |
| 05/08/2008 | US20080108653 Tripeptidyl peptidase inhibitors |
| 05/08/2008 | US20080108625 Substituted Triazole Derivatives as Oxytocin Antagonists |
| 05/08/2008 | US20080108623 N-(4-(1-(2,6-difluorobenzyl)-5(((2-methoxyethyl)(methyl)amino)methyl)-2,4-dioxo-3-(2-pyridinyl)-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-N'-methoxyurea; gonadotropin releasing hormone (GnRH) antagonist; sex hormone dependent disease, antitumor agent |
| 05/08/2008 | US20080108615 such as 4-(1-Hydroxyimino-indan-5-yl)-5-pyridin-4-yl-1H-imidazole-2-carboxylic acid (2-morpholin-4-yl-ethyl)-amide; anticarcinogenic agents, neurodegenerative diseases, brain disorders, stroke, antischemic agent |
| 05/08/2008 | US20080108609 Benzoxazole Carboxamides For Treating CINV and IBS-D |
| 05/08/2008 | US20080108605 Anxiolytic agents with reduced sedative and ataxic effects |
| 05/08/2008 | US20080108600 Polycyclic Pyridines as Potassium Ion Channel Modulators |
| 05/08/2008 | US20080108566 Analogues of GLP-1 |
| 05/08/2008 | US20080108545 Peptide nucleic acid linked via a disulfide bond to a triphenylphosphonium group; deliver PNA oligomers across the plasma membrane into cells; HIV infection, hepatitis C infection; melanoma, pancreatic adnocarcinoma, actue myeloid leukemia, myeloma, small cell lung cancer, prostate cancer |
| 05/08/2008 | US20080107655 Interferon specific immunoglobulin for use in diagnosis, prevention and treatment of autoimmune diseases |
| 05/08/2008 | US20080107650 Administering (S,S)-2-[1-carboxy-2-[3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl]-ethylamino]-4-methylpentanoic acid for treatment of inflammatory bowel disease, Crohn's disease; corticosteroid free therapy |
| 05/08/2008 | US20080107627 Use of sarp-1 for the treatment and/or prevention of scleroderma |
| 05/08/2008 | US20080107612 Anti-caries dental material |
| 05/08/2008 | US20080107608 selective modulators of corticotropin -releasing factor (CRF) receptors, central and periphereal nervous system disorders; antidepressant, anxiolytic agent; stress, cardiovascular disorders, and eating disorders; probes for the localization of CRF receptors |
| 05/08/2008 | DE202007018194U1 CGM Chitin-Glucan-Melanin Kaugummi CGM chitin-glucan gum melanin |
| 05/08/2008 | CA2668551A1 Treatment of gastrointestinal diseases |
| 05/08/2008 | CA2668537A1 Composition for the treatment of gastrointenstinal diseases |
| 05/08/2008 | CA2667211A1 Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (ppar) |
| 05/08/2008 | CA2636788A1 Pharmaceuticals that promote functional regeneration of damaged tissues |
| 05/07/2008 | EP1918377A1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 05/07/2008 | EP1918366A1 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof |
| 05/07/2008 | EP1918272A1 Pharmaceutically active compounds and methods of use |
| 05/07/2008 | EP1917975A1 Novel proteins in Enteroaggregative Escherichia Coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 05/07/2008 | EP1917972A1 Agent for ameliorating heavy metal-induced disorders, and medicinal composition, food and cosmetic containing the same |
| 05/07/2008 | EP1917969A1 Compositions for preventing depletion of the intestinal flora and organ damage following antibiotic treatment |
| 05/07/2008 | EP1917866A1 Method for manufacturing in particular frozen mashed or pureed foods in portions |
| 05/07/2008 | EP1575608B1 Use of cc-chemokine ccl5/rantes mutants against liver diseases |
| 05/07/2008 | EP1436272B1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 05/07/2008 | EP1395269B1 Lipoteichoic acid from lactic acid bacteria for use as medicament and in the treatment of bacterial diseases |
| 05/07/2008 | EP1383774B1 Dihydroimidazo¬4,5-e indole and 7h-pyrrolo¬3,2-f quinoxaline derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 05/07/2008 | EP1250325B1 Phenanthridine-n-oxides |
| 05/07/2008 | EP1137666B1 Glp-1 analogues |
| 05/07/2008 | CN101175754A Novel tetrahydro-1h-pyrido [4,3-b] indole derivatives as cb1' receptor ligands |
| 05/07/2008 | CN101175751A Crystal of indole derivative having piperidine ring and process for production thereof |
| 05/07/2008 | CN101175723A 1,2-di(cyclic) substituted benzene compounds |
| 05/07/2008 | CN101175466A Antibacterial 3',5-disubstituted 2,4'-dihydroxybiphenyl compounds, derivatives and related methods |
| 05/07/2008 | CN101173295A Compositions and methods for identifying antigens which elicit an immune response |
| 05/07/2008 | CN101173228A Novel lactic acid bacillus mycopremna, pharmaceutical composition and uses thereof, and production method |
| 05/07/2008 | CN101172975A Method of preparing five-alkaloid composition of corydalis saxicola bunting |
| 05/07/2008 | CN101172158A Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26 |
| 05/07/2008 | CN101172157A Vibrio parahaemolyticus tunica externa protein ompK subunit vaccine and preparation method thereof |